Letálides cutáneas en un caso de adenocarcinoma rectal: reporte de un caso

Cutaneous metastases from primary malignant tumors are unusual but have significant prognostic value in colorectal cancer patient. We present the case of a 66-year-old male who, in the context of rectal adenocarcinoma, developed perianal cutaneous metastases. At the time of diagnosis, the patient pr...

ver descrição completa

Detalhes bibliográficos
Autores: Torrebella Bonnin, Paula, Lillo Martínez, Paula, Serrano Miralles, Rocío, Lombardo Lliró, Víctor, Gifre Casadevall, Eduard, Pérez-Calvo , Javier, Carbonell Aliaga, Maria Pau
Tipo de documento: artigo
Data de publicação:2025
País:España
Recursos:Conselleria de Salut i Consum del Govern de les Illes Balears
Repositório:Docusalut
Idioma:espanhol
OAI Identifier:oai:docusalut.com:20.500.13003/26690
Acesso em linha:https://hdl.handle.net/20.500.13003/26690
Access Level:Acceso aberto
Palavra-chave:Rectal Adenocarcinoma
Cutaneous Metastases
Diagnosis
Treatment
Survival
Descrição
Resumo:Cutaneous metastases from primary malignant tumors are unusual but have significant prognostic value in colorectal cancer patient. We present the case of a 66-year-old male who, in the context of rectal adenocarcinoma, developed perianal cutaneous metastases. At the time of diagnosis, the patient presented with changes in bowel habits, rectal pain, significant weight loss, and intermittent rectal bleeding. An infiltrating adenocarcinoma of the rectum was observed, and the patient was treated with neoadjuvant chemoradiotherapy followed by radical surgery, during which an exophytic perianal lesion was detected and resected. The pathological anatomy confirmed that it was a cutaneous metastasis of intestinal origin. During follow-up, it recurred twice at the perianal scar. This clinical case highlights the rare and exceptional progression of a patient with cutaneous metastases from colorectal cancer who has survived for more than three years since the initial diagnosis, surpassing the expected average. It underscores the importance of continuous monitoring and appropriate treatment of recurrences and metastases.